Overview

Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE)

Status:
Active, not recruiting
Trial end date:
2022-03-31
Target enrollment:
0
Participant gender:
All
Summary
This study will 1) Evaluate the prevalence of elevated (conditional or abnormal) transcranial Doppler (TCD) velocities in a cross-sectional analysis of children with Sickle Cell Anemia (SCA) living in Tanzania; 2) Obtain longitudinal data on TCD velocities in this population; and 3) Measure the effects of hydroxyurea therapy on TCD velocities and associated primary stroke risk.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborators:
Bugando Medical Centre
The American Society of Hematology
Treatments:
Hydroxyurea
Criteria
Inclusion Criteria:

- Willingness to sign informed consent

- Willingness to follow all study procedures

- Available for study visits for the duration of the study and no plans to move away
from study center.

- Confirmed diagnosis of Sickle Cell Anemia (SCA) by haemoglobin electrophoresis.

- Able to take oral medication and follow hydroxyurea treatment schedule.

Exclusion Criteria:

There are no permanent exclusion criteria for participants to enroll in the screening TCD
portion of SPHERE. Temporary, time-limited exclusion criteria for the screening TCD portion
include the following:

- Febrile illness within the past two weeks. (Temporary Exclusion)

- Hospitalized within the past two weeks. (Temporary Exclusion)

- Transfusion within the past two weeks. (Temporary Exclusion)

Patients who enroll in the screening portion, have a conditional or abnormal TCD, and are
eligible to start hydroxyurea will be excluded from receiving study treatment if they meet
any of the following criteria:

- Abnormal pre-enrolment laboratory values (Temporary Exclusion)

- Known medical condition making participation ill-advised.

- Known allergic reactions to components of hydroxyurea.

- Previous history of stroke.

- Currently pregnant or lactating.